Seeyond’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.45M | Sell |
20,524
-3,003
| -13% | -$359K | 0.24% | 140 |
|
|
2022
Q3 | $2.5M | Buy |
23,527
+764
| +3% | +$81.1K | 0.3% | 90 |
|
|
2022
Q2 | $2.22M | Buy |
22,763
+3,910
| +21% | +$381K | 0.25% | 100 |
|
|
2022
Q1 | $1.77M | Buy |
18,853
+7,896
| +72% | +$740K | 0.18% | 192 |
|
|
2021
Q4 | $933K | Hold |
10,957
| – | – | 0.09% | 376 |
|
|
2021
Q3 | $1.05M | Sell |
10,957
-111
| -1% | -$10.6K | 0.1% | 324 |
|
|
2021
Q2 | $1.08M | Buy |
11,068
+50
| +0.5% | +$4.87K | 0.1% | 307 |
|
|
2021
Q1 | $1.07M | Sell |
11,018
-26,431
| -71% | -$2.57M | 0.11% | 296 |
|
|
2020
Q4 | $3.59M | Sell |
37,449
-12,373
| -25% | -$1.19M | 0.37% | 40 |
|
|
2020
Q3 | $4.79M | Sell |
49,822
-7,856
| -14% | -$755K | 0.52% | 30 |
|
|
2020
Q2 | $7.04M | Buy |
57,678
+53,232
| +1,197% | +$6.49M | 0.8% | 19 |
|
|
2020
Q1 | $128K | Sell |
4,446
-35
| -0.8% | -$1.01K | 0.02% | 538 |
|
|
2019
Q4 | $219K | Buy |
+4,481
| New | +$219K | 0.02% | 535 |
|